Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling

Oncogenic mutations in components of cytokine signaling pathways elicit ligand-independent activation of downstream signaling, enhancing proliferation and survival in acute myeloid leukemia (AML). The myeloproliferative leukemia virus oncogene, MPL, a homodimeric receptor activated by thrombopoietin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pulikkan, John Anto, Madera, Dmitri, Xue, Liting, Bradley, Paul, Landrette, Sean Francis, Kuo, Ya-Huei, Abbas, Saman, Zhu, Lihua Julie, Valk, Peter, Castilla, Lucio Hernán
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2012
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412349/
https://ncbi.nlm.nih.gov/pubmed/22613795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-414649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados